Thorslund Mats, Wastesson Jonas W, Agahi Neda, Lagergren Mårten, Parker Marti G
Aging Research Center, Karolinska Institutet and Stockholm University, Gävlegatan 16, 113 30 Stockholm, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.
Eur J Ageing. 2013;10(4):271-277. doi: 10.1007/s10433-013-0274-8.
The female advantage in life expectancy (LE) is found worldwide, despite differences in living conditions, the status of women and other factors. However, this advantage has decreased in recent years in low-mortality countries. Few researchers have looked at the gender gap in LE in old age (age 65) in a longer historical perspective. Have women always had an advantage in LE at old age and do different countries share the same trends? Life expectancy data for 17 countries were assessed from Human Mortality Database from 1751 to 2007. Since most of the changes in LE taking place today are driven by reductions of old age mortality the gender difference in LE was calculated at age 65. Most low-mortality countries show the same historical trend, a rise and fall of women's advantage in LE at age 65. Three phases that all but two countries passed through were discerned. After a long phase with a female advantage in LE at 65 of <1 year, the gender gap increased significantly during the twentieth century. The increase occurred in all countries but at different time points. Some countries such as England and France had an early rise in female advantage (1900-1919), while it occurred 50 years later in Sweden, Norway and in the Netherlands. The rise was followed by a more simultaneous fall in female advantage in the studied countries towards the end of the century, with exceptions of Japan and Spain. The different timing regarding the increase of women's advantage indicates that country-specific factors may have driven the rise in female advantage, while factors shared by all countries may underlie the simultaneous fall. More comprehensive, multi-disciplinary study of the evolution of the gender gap in old age could provide new hypotheses concerning the determinants of gendered differences in mortality.
尽管生活条件、妇女地位及其他因素存在差异,但女性在预期寿命方面的优势在全球范围内都有体现。然而,近年来在低死亡率国家,这一优势有所下降。很少有研究者从更长的历史视角审视老年(65岁及以上)人群预期寿命的性别差异。女性在老年时的预期寿命是否一直具有优势?不同国家是否呈现相同的趋势?我们评估了人类死亡率数据库中17个国家1751年至2007年的预期寿命数据。由于当前预期寿命的大多数变化是由老年死亡率的降低推动的,因此我们计算了65岁时预期寿命的性别差异。大多数低死亡率国家呈现出相同的历史趋势,即65岁时女性预期寿命优势先上升后下降。除两个国家外,其他国家都经历了三个阶段。在经历了一个女性在65岁时预期寿命优势小于1年的漫长阶段后,20世纪性别差距显著扩大。所有国家都出现了这种扩大,但时间点不同。一些国家,如英国和法国,女性优势较早上升(1900 - 1919年),而瑞典、挪威和荷兰则在50年后才出现。在本世纪末,除日本和西班牙外,研究国家中女性优势随后出现了更为同步的下降。女性优势上升的不同时间点表明,特定国家的因素可能推动了女性优势的上升,而所有国家共有的因素可能是同步下降的基础。对老年性别差距演变进行更全面、多学科的研究,可能会为死亡率性别差异的决定因素提供新的假设。